Glaxosmithkline | Handelsfordringar



Trade Debtors Ändra Datum
AbbVie USD 10.92B 553M 2024-12
Amgen USD 8.13B 1.35B 2025-03
AstraZeneca USD 14.82B 16M 2025-03
Aurora Cannabis CAD 49.52M 9.36M 2024-12
Bausch Health Companies USD 2.07B 68M 2025-03
Bristol-Myers Squibb USD 14.59B 162M 2025-03
Canopy Growth CAD 49.06M 7.2M 2024-12
Corcept Therapeutics USD 53.98M 5.74M 2024-12
Drreddys Laboratories INR 111.49B 8.65B 2024-12
Eli Lilly USD 14B 727.8M 2025-03
GlaxoSmithKline GBP 7.5B 176M 2025-03
Glaxosmithkline GBP 7.32B 542M 2024-12
Indivior 272M 16M 2025-03
J&J USD 16.02B 1.18B 2025-03
Merck USD 11.12B 1.06B 2024-12
Novartis USD 9B 854M 2024-12
Pacira USD 113.3M 12.65M 2024-12
Perrigo USD 686.2M 99.7M 2024-12
Pfizer USD 14.78B 2.92B 2024-12
Prestige Brands USD 167.27M 3.73M 2024-12
Roche Holding CHF 13.46B 984M 2024-12
Sanofi 447M 10.18B 2025-03
Supernus Pharmaceuticals USD 142.08M 3.33M 2024-12
Takeda JPY 735.06B 14.01B 2024-12
Teva Pharmaceutical Industries USD 3.06B 403M 2024-12
Zoetis USD 1.32B 95M 2024-12



Glaxosmithkline Handelsfordringar - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - May 2025.